Drug Trial Radar · NCT02139046
Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout
Last checked: Nov 19, 2026Latest source record: Nov 3, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,790
Actual
Start
Apr 2014
Primary completion
Nov 2015
Study completion Nov 2015
Sponsor
- Lead sponsor
- TakedaTakeda (TAK)
- Sponsor type
- Industry
- First posted
- May 15, 2014
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and safety of febuxostat 40 mg extended release (XR) and 80 mg XR in comparison with febuxostat 40 mg immediate release (IR) and 80 mg IR, respectively, in participants with gout.
Conditions
- Gout
Interventions
Febuxostat IRDrug
Febuxostat IR over-encapsulated tablets
Febuxostat XRDrug
Febuxostat XR over-encapsulated capsules
Febuxostat placeboDrug
Febuxostat placebo-matching capsules
ColchicineDrug
Colchicine tablets
NaproxenDrug
Naproxen tablets
LansoprazoleDrug
Lansoprazole capsules
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Serum Urate <5.0 mg/dL at Month 3Time frame: Month 3
Locations
192 sites in 1 country. Site status is shown where the registry gives one.
Site not named
Binghamton, Alabama
Site not named
Birmingham, Alabama
Site not named
Huntsville, Alabama
Site not named
Gilbert, Arizona
Site not named
Glendale, Arizona
Site not named
Phoenix, Arizona
Site not named
Tucson, Arizona
Site not named
Fayetteville, Arkansas
Site not named
Little Rock, Arkansas
Site not named
Searcy, Arkansas
Site not named
Bellflower, California
Site not named
Carmichael, California
Site not named
Costa Mesa, California
Site not named
Covina, California
Site not named
El Cajon, California
Site not named
Encinitas, California
Site not named
Encino, California
Site not named
Escondido, California
Site not named
Gold River, California
Site not named
Irvine, California
Site not named
Lancaster, California
Site not named
Lomita, California
Site not named
Long Beach, California
Site not named
Los Angeles, California
Site not named
Monterey Park, California
Site not named
Murrieta, California
Site not named
North Hollywood, California
Site not named
Norwalk, California
Site not named
Paramount, California
Site not named
Rancho Cucamonga, California
Site not named
Riverside, California
Site not named
Roseville, California
Site not named
Sacramento, California
Site not named
San Diego, California
Site not named
San Jose, California
Site not named
San Ramon, California
Site not named
Santa Clarita, California
Site not named
Tustin, California
Site not named
Upland, California
Site not named
Arvada, Colorado
Showing 40 of 192 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.